<?xml version="1.0" encoding="UTF-8"?>
<XML><RECORDS>
<RECORD>
	<REFERENCE_TYPE>0</REFERENCE_TYPE>
	<AUTHORS>
		<AUTHOR>Ruckmani,K.</AUTHOR>
		<AUTHOR>Muneera,M.S.</AUTHOR>
		<AUTHOR>Vijaya,R.</AUTHOR>
	</AUTHORS>
	<YEAR>2000</YEAR>
	<TITLE>Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics,</TITLE>
	<SECONDARY_TITLE>Boll. Chim.Farmac Anno</SECONDARY_TITLE>
	<VOLUME>139(5)</VOLUME>
	<PAGES>1-4</PAGES>
	<KEYWORDS>
		<KEYWORD>ketorolac</KEYWORD>
		<KEYWORD>tromethamine,ketorolac</KEYWORD>
		<KEYWORD>formulation,sustained</KEYWORD>
		<KEYWORD>release</KEYWORD>
		<KEYWORD>formulations</KEYWORD>
	</KEYWORDS>
	<ABSTRACT>Matrix type formulations with dicalcium phosphate dihydrate (DCPD) using a polymeric binder (Eudragit RSPM) to obtain controlled release of Ketorolac tromethamine (KT) has been investigated. The drug, DCPD and Eudragit RSPM were granulated using isopropyl alcohol with and without a plasticizer (Diethyl phthalate, DEP). Addition of Eudragit appear to affect the release profile. However, addition of a plasticizer had a significant effect on the rate of release. The release appears to follow first order kinetics and the rate constant decreased linearly with increasing DEP concentration. A directly compressible mixture was also formulated by coating DCPD particles with DEP with and without Eudragit RSPM.</ABSTRACT>
</RECORD>
</RECORDS></XML>